Collagen-based wound dressing for doxycycline delivery: In-vivo evaluation in an infected excisional wound model in rats

Journal of Pharmacy and Pharmacology

Volumn 61, Issue 12, 2009, Pages 1617-1623

  Adhirajan, Natarajan ^a   Shanmugasundaram, Natesan ^a   Shanmuganathan, Seetharaman ^a   Babu, Mary ^a  

^a CENTRAL LEATHER RESEARCH INSTITUTE   (India)

Author keywords

Collagen; Doxycycline; Metalloproteases; Wound dressing; Wound healing

Indexed keywords

COLLAGEN; DOXYCYCLINE; GELATINASE A; GELATINASE B; HEXOSAMINE; MICROSPHERE; NEUTROPHIL COLLAGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; FEMALE; GRANULATION TISSUE; NONHUMAN; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RAT; WOUND DRESSING; WOUND INFECTION;

EID: 75749100655     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.61.12.0005     Document Type: Article

References (30)

1. Diegelmann RF, Evans MC. An overview of acute, fibrotic and delayed healing. Front Biosci 2004; 9: 283-289.
2. Richard P et al. Pseudomonas aeruginosa outbreak in a burn unit: role of antimicrobials in the emergence of multiply resistant strains. J Infect Dis 1994; 170: 377-383.
3. Mi FL et al. Control of wound infections using a bilayer chitosan wound dressing with sustainable antibiotic delivery. J Biomed Mater Res 2002; 59: 438-449.
4. Sripriya R et al. Improved collagen bilayer dressing for the controlled release of drugs. J Biomed Mater Res B Appl Biomater 2004; 70B: 389-396.
5. Meaume S et al. Evaluation of a silver releasing hydroalginate dressing in chronic wounds with signs of local infection. J Wound Care 2005; 14: 411-419.
6. Shanmugasundaram N et al. Design and delivery of silver sulfadiazine from alginate microspheres - impregnated collagen scaffold. J Biomed Mater Res B Appl Biomater 2006; 77B: 378-388.
7. Temperini C et al. N-Hydroxyurea - a versatile zinc binding function in the design of metalloenzyme inhibitors. Bioorg Med Chem Lett 2006; 16: 4316-4320.
8. Rayment RA et al. Attenuation of protease activity in chronic wound fluid with bisphosphonate-functionalised hydrogels. Biomaterials 2008; 29: 1785-1795.
9. Vincenti MP et al. Using inhibitors of metalloproteinases to treat arthritis. Easier said than done? Arthritis Rheum 1994; 37: 1115-1126.
10. Gendron R et al. Effect of microbial siderophores on matrix metalloproteinase-2 activity. J Periodontal Res 1999; 34: 50-53.
11. Cullen B et al. Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers. Wound Repair Regen 2002; 10: 16-25.
12. Schönfelder U et al. Influence of selected wound dressings on PMN elastase in chronic wound fluid and their antioxidative potential in vitro. Biomaterials 2005; 26: 6664-6673.
13. Chaturvedi R et al. Evaluation of the regenerative potential of 25% doxycycline loaded biodegradable membrane Vs biodegradable membrane alone in the treatment of human periodontal infrabony defects: a clinical and radiological study. Indian J Dent Res 2008; 19: 116-123.
14. Wenk J et al. Selective pick up of increased iron by deferoxamine coupled cellulose abrogates the iron driven induction of matrix degrading metalloproteinase 1 and lipid peroxidation in human dermal fibroblasts in vitro: a new dressing concept. J Invest Dermatol 2001; 116: 833-839.
15. Vachon DJ, Yager DR. Novel sulfonated hydrogel composite with the ability to inhibit proteases and bacterial growth. J Biomed Mater Res A 2006; 76: 35-43.
16. Adhirajan N et al. Functionally modified gelatin microspheres impregnated collagen scaffold as novel wound dressing to attenuate the proteases and bacterial growth. Eur J Pharm Sci 2009; 36: 235-245.
17. Adhirajan N et al. Gelatin microspheres crosslinked with EDC as a drug delivery system for doxycycline: development and characterization. J Microencapsul 2007; 24: 659-671.
18. Grzybowski J et al. A new anti-infective collagen dressing containing antibiotics. J Biomed Mater Res 1997; 36: 163-166.
19. Culling CFA. Handbook of Histopathological and Histological Techniques, 3rd edn. London: Butterworth, 1974.
20. Woessner JF et al. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 1961; 93: 440-447.
21. Elson LA, Morgan WT. A colorimetric method for the determination of glucosamine and chondrosamine. Biochem J 1933; 27: 1824-1828.
22. Smith PK et al. Measurement of protein using bicinchoninic Acid. Anal Biochem 1985; 150: 76-85.
23. Bergstrom N et al. Clinical practice guideline: treatment of pressure ulcers. Rockville MD: US Department of Health and Human Services, Public Health Service Agency for Health Care Policy and Research, 1994.
24. Raju DR et al. A study of the critical bacterial inoculum to cause a stimulus to wound healing. Surg Gynecol Obstet 1977; 144: 347-350.
25. Young PK, Grinell F. Metalloproteinases activation cascade after burn injury: a longitudinal analysis of human wound environment. J Invest Dermatol 1994; 103: 660-664.
26. Baie SH, Sheikh KA. The wound healing properties of Channa striatus-cetrimide cream: tensile strength measurement. J Ethnopharmacol 2000; 71: 93-100.
27. Chithra P et al. Influence of Aloe vera on collagen turnover in healing of dermal wounds in rats. Indian J Exp Biol 1998; 36: 896-901.
28. Salo T et al. Expression of matrix metalloproteinase 2 and 9 during early human wound healing. Lab Invest 1994; 70: 176-182.
29. Inkinen K et al. Expression and activity of matrix metalloproteinase 2 and 9 in experimental granulation tissue. APMIS 2000; 108: 318-328.
30. Miyajima S et al. Matrix metalloproteinases induction by pseudomonal virulence factors and inflammatory cytokines in vitro. Microb Pathog 2001; 31: 271-281.